Exchange: NASDAQ·Updated 05:18 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

-$0.15

Reported EPS

-$0.16

Surprise

-9.8%

Estimated Rev

$49.16M

Reported Rev

$47.3M

Surprise

-3.78%

• Reported GAAP EPS of -$0.16 down -166.67% YoY • Reported revenue of $47.28M down -24.01% YoY • LifeMD expects full year 2026 revenue of $205.5 million to $212.5 million and adjusted EBITDA of negative $6.0 million to breakeven, including launch costs for the XYOSTED auto-injector product.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.15
--
--
N/A
Q2 '26
-$0.15
-$0.16
-9.80%
MISSED
Q1 '26
-$0.21
-$0.20
2.78%
BEAT
Q4 '25
-$0.07
$0.41
723.92%
BEAT
Q3 '25
-$0.02
-$0.10
-400.00%
MISSED

Advertisement|Remove ads.